Hydrocortisone

Related products

• 

  Hereditary angioedema

  Prednisone acetate

  【Product name】PRED-G

  [English common name]Prednisone Acetate

  [Chinese common name]Prednisone acetate

  [English name]Qiangdisong, Prednisone

  [Chinese other name]Prednisone, prednisone

  [indications]
  Prednisone acetate tablets: This product is mainly used for allergic and autoimmune inflammatory diseases. Suitable for connective tissue disease, systemic lupus erythematosus, severe polymyositis, severe bronchiasthma, dermatomyositis, vasculitis and other allergic diseases,Acute leukemia,Malignant lymphoma. And other conditions suitable for other adrenocortical drugs.
  Prednisolone acetate eye drops: This product is suitable for short-term treatment of steroid-sensitive eye inflammation (excluding viral, fungal and bacterial pathogen infections).
  Prednisone acetate ointment: adrenocortical hormone drugs. This product is suitable for allergic conjunctivitis, keratitis, conjunctivitis, tendinitis, red eyes, dacryocystitis and other eye injuries.
  Prednisolone acetate injection: This product is mainly used for allergic and autoimmune inflammatory diseases. It is now used for active rheumatism, rheumatoid arthritis, lupus erythematosus, severe bronchial asthma, nephrotic syndrome, thrombocytopenic purpura, neutropenia, various adrenal insufficiency, severe dermatitis, acute leukemia, etc. Comprehensive treatment for certain infections.

  【Dosage】
  Prednisone acetate tablets:
  1. Oral usually 5 ~ 10mg (1 ~ 2 tablets), 10 ~ 60mg a day (2 ~ 12 tablets).
  2. For autoimmune diseases such as systemic lupus erythematosus, stomach syndrome, ulcerative colitis, autoimmune hemolytic anemia, 40 to 60 mg per day can be given, and the condition is gradually reduced after the condition is stable.
  3. For allergic diseases such as drug dermatitis, urticaria, bronchial asthma, etc., prednisone can be given 20 to 40 mg per day. After the symptoms are alleviated, the amount is reduced, and the amount is reduced by 5 mg every 1 to 2 days.
  4. To prevent rejection of organ transplants, generally take 100mg daily for 1 to 2 days before surgery, and change to 60mg per day for one week after surgery, and then gradually reduce the amount.
  Prednisolone acetate eye drops: drip into the conjunctival sac. 1 to 2 drops at a time, 2 to 4 times a day. 24 to 48 hours from the start of treatment, the dose can be increased to 2 drops per hour as appropriate. Be careful not to stop the drug too early.
  Prednisone acetate eye ointment: once a night before bedtime, applied to the conjunctival sac.
  Prednisolone acetate injection: intramuscular or intra-articular injection: 10 ~ 40mg a day, if necessary, can increase the amount.

  [Storage]
  Prednisone acetate tablets: sealed and protected from light.
  Prednisolone acetate eye drops: Store at room temperature (15 ~ 25 ° C), do not freeze.
  Prednisone acetate ointment: shading, sealed storage.
  Prednisolone acetate injection: shading, sealed and stored.

  [Tips] Some of the information on this site comes from the Internet and is only used internally by pharmacists or medical staff. It is not a substitute for doctors to diagnose face to face. Please consult a professional pharmacist for specific medications. Please refer to the actual product manual or the actual product for the product content.
• 

  Hereditary angioedema

  Danazol

  【Product name】Danazol Capsules

  [English common name]Danazol

  [Chinese common name]Danazol

  [English name]Danocrine, Danol

  [Chinese other name]Anthazole, danazol

  [indications]Mainly used for treatmentEndometriosis. Also used to treat fibrous mastitis, male breast development, breast pain, dysmenorrhea, abdominal pain, etc., can make the mass disappear, soften or shrink, so that the pain disappears or reduces. Also used for the treatment of precocious puberty, primary thrombocytopenic purpura,hemophiliaAnd Christmas disease,Hereditary angioedema, systemic lupus erythematosus and so on.

  【Dosage】oral:
  1. forEndometriosisFrom the first to the third day of the menstrual cycle, 200mg each time, 2 times a day, the total amount of no more than 800mg a day, for 3 consecutive months for a course of treatment.
  2. Fibrous mastitis, daily 100 ~ 400mg, 2 times, for 3-6 months.
  3. Male breast development, 200 ~ 600mg daily.
  4. Precocious puberty, 200 ~ 400mg daily.
  5. Thrombocytopenic purpura, 200mg each time, 2-4 times a day.
  6. Hemophilia, 600mg daily, for 14 days.
  7. Hereditary angioedema, starting 600mg daily, 3 times divided, 6 to 12 weeks after the daily reduction of 100 ~ 200mg, until the symptoms can be controlled.
  8. Lupus erythematosus, 400 to 600 mg daily.

  [Storage]Shading, sealed and stored.

  [Tips] Some of the information on this site comes from the Internet and is only used internally by pharmacists or medical staff. It is not a substitute for doctors to diagnose face to face. Please consult a professional pharmacist for specific medications. Please refer to the actual product manual or the actual product for the product content.
• 

  Crohn's disease , Behcet disease

  Infliximab

  【Product name】REMICADE, Remicade

  [English common name]Infliximab

  [Chinese common name]Infliximab

  [English name]

  [Chinese other name]

  [indications]
  Rheumatoid Arthritis
  This product is a disease-control anti-rheumatic drug. For patients with moderate to severe active rheumatoid arthritis, this product can be used in combination with methotrexate:
  · Reduce symptoms and signs;
  · Improve physical function and prevent disability in patients.
  Crohn's disease
  For patients with moderate to severe active Crohn's disease who are not well received by traditional treatment, this product can be used for:
  · Reduce symptoms and signs;
  · Achieve and maintain clinical efficacy;
  · Promote mucosal healing;
  · Improve the quality of life;
  · Reduce the amount of corticosteroids or stop using corticosteroids.
  Tracheal Crohn's disease
  For patients with fistile Crohn's disease, this product can be used for:
  Reduce the number of intestinal-cutaneous fistulas and rectal-vaginal fistulas to promote and maintain fistula healing;
  · Reduce symptoms and signs;
  · Improve the quality of life.
  Ankylosing spondylitis
  For patients with active ankylosing spondylitis, this product can be used for:
  · Alleviate symptoms and signs, including increasing the range of activity;
  · Improve physical function;
  · Improve the quality of life.
  psoriasis
  For patients with psoriasis, this product can be used for:
  Adult patients with chronic severe plaque psoriasis who require systemic treatment and are ineffective, contraindicated or tolerant to other systems such as cyclosporine, methotrexate or photochemotherapy. This product is intended for use only in patients who are treated under close supervision by a physician and regularly followed up by a physician.

  【Dosage】
  Usage: intravenous infusion.
  Rheumatoid Arthritis
  The product was administered 3 mg/kg for the first time, and then the same dose was administered once every 8 weeks after the second week and the sixth week after the first administration and thereafter. This product should be combined with methotrexate. For patients with poor efficacy, consider adjusting the dose to 10 mg/kg and/or adjusting the medication interval to 4 weeks.
  Moderate and severe active Crohn's disease, fistula Crohn's disease
  The product was administered 5 mg/kg for the first time, and then the same dose was administered once every 8 weeks after the second week and the sixth week after the first administration and thereafter. For patients with poor efficacy, consider adjusting the dose to 10 mg/kg.
  Ankylosing spondylitis
  The product was administered 5 mg/kg for the first time, and then the same dose was administered once every 6 weeks after the second week and the sixth week after the first administration and thereafter.
  User guides
  Sterility should be performed.
  1. Calculate the dosage and determine the number of bottles used in this product: This product contains 100mg of infliximab per bottle, and calculate the total amount of the solution to be prepared.
  2. Dissolve each bottle of medicine with 10 ml of sterile water for injection using a syringe equipped with a 21 gauge (0.8 mm) or smaller needle: remove the flip of the vial, wipe the top of the vial with a medical alcohol swab, and insert the syringe needle into the vial Cover, inject sterile water for injection. If the vacuum in the vial has been destroyed, the bottle cannot be used. Gently rotate the vial to dissolve the powder. Avoid shaking for a long time or with force. Do not oscillate. Foam may appear during the dissolution of the drug. After 5 minutes of storage, the solution should be colorless or light yellow, and the milk is white. Since infliximab is a protein, there may be some translucent particles in the solution. If opaque particles, discoloration or other substances appear in the solution, they cannot be used any more.
  3. Dilute the sterile aqueous solution of this product to 250 ml with 0.9% sodium chloride injection: withdraw the same amount of liquid from the 250 ml 0.9% sodium chloride injection bottle or bag as the sterile injectable aqueous solution of this product. The sterile aqueous solution for injection of this product is completely injected into the infusion bottle or bag and gently mixed.
  4. The infusion time should not be less than 2 hours: the infusion set should be equipped with a built-in, sterile, pyrogen-free, low protein binding filter (pore size ≤ 1.2 μm). Unused infusions should not be stored for further use.
  5. The physical and biochemical compatibility studies of this product in combination with other drugs have not been carried out, and this product should not be infused simultaneously with other drugs.
  Products administered parenterally should be visually inspected for the presence of particulate matter or discoloration prior to administration. If opaque particles, discoloration, or other foreign matter are found, the drug may not be used.
  Plaque psoriasis
  The product was administered 5 mg/kg for the first time, and then the same dose was administered once every 8 weeks after the second week and the sixth week after the first administration and thereafter. If the patient does not respond after week 14 (ie, after 4 doses), the product should not be treated.
  Psoriasis patients re-administered
  Patients with psoriasis have limited experience with a single administration after 20 weeks, suggesting a reduction in the effectiveness of the product compared to the initial induction therapy and an increase in mild to moderate infusion response.
  After relapse of the disease, limited experience with repeated induction therapy showed an increase in infusion response (including severe reactions) compared to 8-week maintenance therapy.
  If treatment interruption is maintained, it is not recommended to initiate induction therapy again and should be re-administered according to maintenance therapy.

  [Storage]Store at 2-8 °C in the dark.

  [Tips] Some of the information on this site comes from the Internet and is only used internally by pharmacists or medical staff. It is not a substitute for doctors to diagnose face to face. Please consult a professional pharmacist for specific medications. Please refer to the actual product manual or the actual product for the product content.
• 

  Crohn's disease , Optic neuromyelitis

  Methylprednisolone

  【Product name】Medrol

  [English common name]Methylprednisolone

  [Chinese common name]Methylprednisolone

  [English name]Methylprednisolone, A-Methapred, Adlone-40, Adlone-80

  [Chinese other name]A strong dragon, 6a-methylprednisolone, methylprednisolone, methylprednisolone

  [Indications] Mainly used for indications of allergic and autoimmune inflammatory diseases.

  【Dosage】
  1. According to the treatment needs of different diseases, the initial dose of methylprednisolone tablets can be adjusted between 4mg and 48mg of methylprednisolone per day.
  (1) Patients with mild symptoms usually receive a lower dose; some patients may require a higher initial dose.
  (2) Diseases that are clinically required to be treated with higher doses include multiple sclerosis (200 mg/day), cerebral edema (200-1000 mg/day), and organ transplantation (up to 7 mg/kg/day).
  (3) If there is no satisfactory clinical effect after sufficient treatment for a period of time, the methylprednisolone tablet should be discontinued and other suitable treatment methods should be used.
  (4) If it is necessary to stop the drug after long-term treatment, it is recommended to reduce the amount by volume, and not to withdraw the drug suddenly.

  [Storage] sealed, stored at 15 ° C -25 ° C.

  [Tips] Some of the information on this site comes from the Internet and is only used internally by pharmacists or medical staff. It is not a substitute for doctors to diagnose face to face. Please consult a professional pharmacist for specific medications. Please refer to the actual product manual or the actual product for the product content.